Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
East Mediterr Health J ; 29(4): 232-235, 2023 Apr 27.
Article in English | MEDLINE | ID: covidwho-20245497
2.
Rheumatol Int ; 42(12): 2151-2158, 2022 12.
Article in English | MEDLINE | ID: covidwho-1990615

ABSTRACT

Vaccine hesitancy is considered a major barrier to achieving herd immunity against COVID-19. While multiple alternative and synergistic approaches including heterologous vaccination, booster doses, and antiviral drugs have been developed, equitable vaccine uptake remains the foremost strategy to manage pandemic. Although none of the currently approved vaccines are live-attenuated, several reports of disease flares, waning protection, and acute-onset syndromes have emerged as short-term adverse events after vaccination. Hence, scientific literature falls short when discussing potential long-term effects in vulnerable cohorts. The COVAD-2 survey follows on from the baseline COVAD-1 survey with the aim to collect patient-reported data on the long-term safety and tolerability of COVID-19 vaccines in immune modulation. The e-survey has been extensively pilot-tested and validated with translations into multiple languages. Anticipated results will help improve vaccination efforts and reduce the imminent risks of COVID-19 infection, especially in understudied vulnerable groups.


Subject(s)
COVID-19 , Antiviral Agents , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Pandemics/prevention & control , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL